Hypothesis

Aged CD8⁺ T cells with defective mitochondria release mitochondrial reactive oxygen species (mtROS) that diffuse into adjacent stromal fibroblasts, triggering a DNA‑damage‑dependent SASP that converts those fibroblasts into a senescent, pro‑inflammatory niche. This niche then amplifies tissue‑wide senescence and inflammaging, making immune‑derived mtROS a upstream driver of organismal aging rather than a downstream consequence.

Mechanistic Basis

• Mitochondrial dysfunction in senescent T cells – Recent work shows that accumulated senescent T cells harbor depolarized mitochondria that overproduce mtROS [2].
• ROS diffusion to stromal compartments – mtROS can exit cells via voltage‑dependent anion channels and oxidize extracellular thiols, creating a redox gradient that penetrates fibroblast membranes [3].
• DNA damage‑induced fibroblast senescence – Oxidative base lesions activate ATM‑p53‑p21 signaling in fibroblasts, leading to a stable growth arrest and a SASP rich in IL‑6, IL‑8, and MMPs [1].
• Positive feedback loop – Fibroblast‑derived SASP further stresses neighboring immune cells, deepening mitochondrial impairment and sustaining mtROS efflux.

Predictions & Experimental Design

1. Spatial correlation – In aged murine tissues, mtROS‑high CD8⁺ T cells will be physically adjacent (<10 µm) to fibroblasts displaying γH2AX⁺ foci and SASP expression. Test: multiplexed ion beam imaging (MIBI) combined with MitoSOX staining; quantify co‑localization frequencies in young vs. old mice.
2. Causality via mtROS scavenging – Targeted expression of mitochondrial‑targeted catalase (mCAT) in T cells will reduce fibroblast senescence markers without altering T‑cell numbers. Test: Cd8‑Cre‑mCAT mice; measure fibroblast p16^Ink4a^ and SASP cytokines in spleen and liver at 20 months.
3. Rescue of systemic aging phenotypes – mCAT‑expressing T‑cell mice will exhibit improved grip strength, enhanced glucose tolerance, and lower circulating IL‑6 compared with littermate controls. Test: longitudinal phenotyping cohort (n=15 per group).
4. Human relevance – Peripheral blood from older donors will show a subset of CD8⁺CD57⁺ T cells with high MitoSOX signal that correlates positively with plasma fibroblast activation marker (FAP) levels. Test: flow cytometry and ELISA on samples from the Baltimore Longitudinal Study of Aging.

Potential Confounds & Controls

• Off‑target antioxidant effects – Use a T‑cell‑specific mitochondrial uncoupler (e.g., AAV‑Cd8‑UCP1) to increase ROS as a converse experiment; expect accelerated fibroblast senescence.
• Compensatory immune changes – Monitor total lymphocyte subsets and cytokine profiles to ensure observed effects are not secondary to broad immunosuppression or hyper‑inflammation.
• Microbiota influence – Cohouse mice or treat with broad‑spectrum antibiotics to rule out microbiota‑driven inflammaging as the primary driver.

If mtROS from senescent T cells demonstrably initiates fibroblast senescence and manipulating this axis alters systemic aging readouts, the hypothesis gains support. Conversely, if fibroblast senescence persists despite T‑cell‑specific mtROS neutralization, the claim that immune‑derived mtROS is a primary driver would be falsified.